NASDAQ$AKYA
Akoya Biosciences Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Akoya reported record revenue and instrument placements in Q1 2023.
Akoya Biosciences reported a strong start to 2023 with record quarterly revenue of $21.4 million, representing a 27% year-over-year growth. The company also achieved a milestone of 1000 spatial instrument placements in April. Akoya is reiterating its full-year 2023 revenue guidance range of $95-98 million.
- Total revenue reached $21.4 million, a 26.6% increase compared to the prior year period.
- Product revenue increased by 16.5% to $15.5 million, with instrument revenue up 12.9% and reagent revenue up 23.9%.
- Service and other revenue increased significantly by 63.9% to $5.9 million.
- The company sold 58 instruments and had an installed base of 992 instruments as of March 31, 2023.
Headline financials
Revenue & EPS history
Akoya · Revenue · Quarterly
$21.4M
Revenue by segment
Akoya · $15.5M total across 1 segment · Q1 2023
- Product revenue$15.5M+16.3%100.0%
Forward guidance
Akoya continues to expect a full year 2023 revenue guidance range of $95-98 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 10 quarterly earnings reports · overlaid with Q1 2023
-3.7%
Avg return
Earnings day
-8.6%
Avg return
5 days after
-17.2%
Avg return
30 days after
53%
10 / 19 earnings
Positive
+13.7%
Q4 2021
Best reaction
-31.9%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | — | — | — | |
| Q1 2025 | +1.0% | +24.8% | +23.8% | |
| Q4 2025 | +3.8% | +9.2% | -30.7% | |
| Q3 2024 | -24.9% | -33.2% | -29.5% | |
| Q2 2024 | -9.5% | -0.9% | +5.5% | |
| Q1 2024 | -31.9% | -35.1% | -50.0% | |
| Q4 2023 | -15.4% | -17.1% | -28.1% | |
| Q3 2023 | +10.0% | +6.9% | +16.4% | |
| Q2 2023 | +0.9% | -6.5% | -23.9% | |
| Q1 2023 | -2.5% | -17.1% | -18.8% | |
| Q4 2022 | -7.3% | -17.2% | -36.6% | |
| Q3 2022 | -15.1% | — | — | |
| Q2 2022 | +5.0% | — | — | |
| Q1 2022 | -11.9% | — | — | |
| Q4 2021 | +13.7% | — | — | |
| Q3 2020 | +1.5% | — | — | |
| Q3 2021 | +0.2% | — | — | |
| Q2 2021 | -0.1% | — | — | |
| Q4 2020 | +9.5% | — | — | |
| Q1 2021 | +2.3% | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro